These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 29188462)

  • 1. Quantification of retinal changes after resolution of submacular hemorrhage secondary to polypoidal choroidal vasculopathy.
    Kim JH; Chang YS; Lee DW; Kim CG; Kim JW
    Jpn J Ophthalmol; 2018 Jan; 62(1):54-62. PubMed ID: 29188462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
    Kitagawa Y; Shimada H; Mori R; Tanaka K; Yuzawa M
    Ophthalmology; 2016 Jun; 123(6):1278-86. PubMed ID: 26949121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Lee H; Ji B; Chung H; Kim HC
    Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-vascular endothelial growth factor monotherapy in the treatment of submacular hemorrhage secondary to polypoidal choroidal vasculopathy.
    Cho HJ; Koh KM; Kim HS; Lee TG; Kim CG; Kim JW
    Am J Ophthalmol; 2013 Sep; 156(3):524-531.e1. PubMed ID: 23769197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of polypoidal lesion-selective photodynamic therapy with intravitreal antivascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Komuku Y; Iwahashi C; Gomi F
    Jpn J Ophthalmol; 2020 May; 64(3):265-270. PubMed ID: 32206935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-month results of intravitreal aflibercept injections for patients with polypoidal choroidal vasculopathy.
    Hosokawa M; Shiraga F; Yamashita A; Shiragami C; Ono A; Shirakata Y; Kimura S; Shiode Y; Kawata T; Hosogi M; Fujiwara A; Morizane Y
    Br J Ophthalmol; 2015 Aug; 99(8):1087-91. PubMed ID: 25712826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperpigmented spots after treatment for submacular hemorrhage secondary to polypoidal choroidal vasculopathy.
    Kim JH; Chang YS; Kim CG; Lee DW; Han JI
    Graefes Arch Clin Exp Ophthalmol; 2018 Mar; 256(3):469-477. PubMed ID: 29302789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization.
    Kim JH; Chang YS; Kim JW; Kim CG; Yoo SJ; Cho HJ
    Ophthalmology; 2014 Apr; 121(4):926-35. PubMed ID: 24342019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection.
    Saito M; Kano M; Itagaki K; Ise S; Imaizumi K; Sekiryu T
    Jpn J Ophthalmol; 2016 Jan; 60(1):35-41. PubMed ID: 26350229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy.
    Yamamoto A; Okada AA; Kano M; Koizumi H; Saito M; Maruko I; Sekiryu T; Iida T
    Ophthalmology; 2015 Sep; 122(9):1866-72. PubMed ID: 26088619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal Aflibercept and Ranibizumab Injections for Polypoidal Choroidal Vasculopathy.
    Cho HJ; Kim KM; Kim HS; Han JI; Kim CG; Lee TG; Kim JW
    Am J Ophthalmol; 2016 May; 165():1-6. PubMed ID: 26921806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypoidal choroidal vasculopathy in patients aged less than 50 years: characteristics and 6-month treatment outcome.
    Chang YS; Kim JH; Kim JW; Lee TG; Kim CG; Cho SW
    Graefes Arch Clin Exp Ophthalmol; 2016 Jun; 254(6):1083-9. PubMed ID: 26384678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator.
    Kimura S; Morizane Y; Hosokawa M; Shiode Y; Kawata T; Doi S; Matoba R; Hosogi M; Fujiwara A; Inoue Y; Shiraga F
    Am J Ophthalmol; 2015 Apr; 159(4):683-9. PubMed ID: 25555798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ONE-YEAR RESULTS OF INTRAVITREAL AFLIBERCEPT FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Hara C; Sawa M; Sayanagi K; Nishida K
    Retina; 2016 Jan; 36(1):37-45. PubMed ID: 26383709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-year visual outcomes of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy.
    Sakai T; Okano K; Kohno H; Tsuneoka H
    Acta Ophthalmol; 2016 Dec; 94(8):e765-e771. PubMed ID: 27237048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal Anti-vascular Endothelial Growth Factor for Newly Diagnosed Symptomatic Polypoidal Choroidal Vasculopathy with Extrafoveal Polyps.
    Kim JH; Lee DW; Choi SC; Kim JW; Lee TG; Kim CG; Cho HJ
    Korean J Ophthalmol; 2015 Dec; 29(6):404-10. PubMed ID: 26635457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal pigment epithelial atrophy after anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy.
    Cho HJ; Kim K; Lim SH; Kang DH; Kim JW
    Br J Ophthalmol; 2020 Oct; 104(10):1443-1447. PubMed ID: 31896542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence Rate of Massive Submacular Hemorrhage and its Risk Factors in Polypoidal Choroidal Vasculopathy.
    Cho JH; Ryoo NK; Cho KH; Park SJ; Park KH; Woo SJ
    Am J Ophthalmol; 2016 Sep; 169():79-88. PubMed ID: 27318076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the arm-to-choroidal circulation time and clinical profile in patients with polypoidal choroidal vasculopathy.
    Mukai R; Itagaki K; Honjyo J; Tanaka K; Norikawa K; Sekiryu T
    Jpn J Ophthalmol; 2024 May; 68(3):211-215. PubMed ID: 38609716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Underlying Causes of Spontaneous Submacular Hemorrhage by Indocyanine Green Angiography.
    Kim H; Lee SC; Kim SM; Lee JH; Koh HJ; Kim SS; Byeon SH; Kim M; Lee CS
    Ophthalmologica; 2015; 233(3-4):146-54. PubMed ID: 25833061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.